Multiplikator Forward P/S: NanoVibronix (NAOV)

NanoVibronix - logo grafis emiten NAOV

An optimized supply chain and internal reserves minimize procurement disruptions, which is supported by a forward price-to-sales valuation with a metric value of 1.60. NanoVibronix, Inc. (NAOV) is protected by strict FDA regulations and unique WoundWand patents. Business resilience is further bolstered by the development of wearable ultrasound systems for rehabilitation and home use, which expand the company's target markets.

nanovibronix.com - Kapitalisasi marang prakiraan pendapatan NAOV (periode 04.07.2022 - 12.12.2025)

Ringkesan rincian data analitis NanoVibronix (NAOV)

- rega pasar lan target rega analis:
Analisis fundamental perusahaan:NAOV (NanoVibronix)
Sampel barang nanovibronix.com

Amidst a conservative therapeutic ultrasound market and slow insurance approval for procedures, the expected P/S ratio helps assess the justification of NanoVibronix, Inc. (NAOV) market value relative to its potential. This indicator compares current market capitalization with projected revenue, allowing investors to determine the control premium and identify asset overbought conditions as the chart approaches historical extremes.

Karo sapa NanoVibronix, Inc. saingan

Rasio rega marang prakiraan pendapatan Dexcom CGM DXCM|Penumbra Corp (PEN) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Novanta Inc - Multiplikator Forward P/S|HAE (Haemonetics Corporation) - Kapitalisasi marang prakiraan pendapatan|INSP: Multiplikator Forward P/S|Kapitalisasi marang prakiraan pendapatan PRCT|CNMD (CONMED Inc.) - Multiplikator Forward P/S|Pulse Corp (PLSE) - Rasio kapitalisasi marang dodolan sing dikarepake|Multiplikator Forward P/S INMD|Multiplikator Forward P/S picardmedical.com (PMI)|Multiplikator Forward P/S SRDX (surmodics.com)|Multiplikator Forward P/S Senseonics Holdings, Inc. SENS|NPCE - Rasio rega marang prakiraan pendapatan|TCMD: Rasio rega marang prakiraan pendapatan|SNWV (Sanuwave Health Inc) - Multiplikator forward rega marang pendapatan|Prakiraan rega marang pendapatan Outset Medical OM|ELMD (SmartVest) - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep LENSAR Inc. LNSR|Rasio rega marang prakiraan pendapatan AVITA Medical Inc. (RCEL)|Profound Medical Corporation (PROF) - Prakiraan rega marang pendapatan|Baird Medical Investment Holdings - Multiplikator forward rega marang pendapatan|Multiplikator Forward P/S EDAP Medical EDAP|Apyx Medical Corp - Multiplikator Forward P/S|Rasio kapitalisasi marang dodolan sing dikarepake IceCure Medical ICCM|Pulmonx (LUNG) - Rasio rega marang prakiraan pendapatan|Rega mangsa ngarep marang pendapatan TELA (TELA Bio Corp)|Rasio rega marang prakiraan pendapatan cytosorbents.com|Multiplikator forward rega marang pendapatan Sensus Healthcare, Inc. (SRTS)|Multiplikator Forward P/S ZYXI|ECOR - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Rasio rega marang prakiraan pendapatan vicarioussurgical.com RBOT|IINN: Kapitalisasi marang prakiraan pendapatan|ICU - Rasio rega marang prakiraan pendapatan|iridex.com - Rasio rega marang pendapatan sing dikarepake|INBS: Multiplikator Forward P/S|XAIR (Beyond Air Inc) - Rasio rega marang prakiraan pendapatan|Rasio rega marang prakiraan pendapatan Profusa, Inc.|SSKN (strataskinsciences.com) - Rasio rega marang pendapatan sing dikarepake|Multiplikator forward rega marang pendapatan GCTK (GlucoTrack Inc.)|Venus Concept - Kapitalisasi marang prakiraan pendapatan|Multiplikator Forward P/S NUWE (Nuwellis Corp)|Rega forward marang dodolan AEMD|ASXC - Rasio rega marang prakiraan pendapatan|Prakiraan rega marang pendapatan Avinger, Inc (AVGR)|BSGM: Multiplikator Forward P/S|Cutera (CUTR) - Multiplikator Forward P/S|KNW (Know Labs) - Multiplikator Forward P/S|Multiplikator forward rega marang pendapatan Inari Medical (NARI)|Rasio rega marang prakiraan pendapatan nevro.com (NVRO)|RSLS (ReShape Lifesciences, Inc.) - Rega forward marang dodolan|Multiplikator Forward P/S SILK (Silk Road Medical)